Eaton Vance Management Catalent, Inc. Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Catalent, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 188,920 shares of CTLT stock, worth $11.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

188,920

Previous 224,692 15.92%

Holding current value

$11.1 Million

Previous $24.1 Million 43.29%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $2.59 Million - $4.05 Million	-35,772 Reduced 15.92%	188,920 $13.7 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $387,342 - $506,610	-4,442 Reduced 1.94%	224,692 $24.1 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $3.9 Million - $5.15 Million	41,396 Added 22.05%	229,134 $25.4 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $26,066 - $30,317	-218 Reduced 0.12%	187,738 $23.8 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $30,130 - $39,288	-276 Reduced 0.15%	187,956 $24.8 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $92,011 - $106,087	917 Added 0.49%	188,232 $20.4 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $91,460 - $112,868	901 Added 0.48%	187,315 $19.7 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $11,851 - $14,539	138 Added 0.07%	186,414 $19.4 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $1,963 - $2,497	-27 Reduced 0.01%	186,276 $16 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $30.7 Million - $50.5 Million	-638,362 Reduced 77.41%	186,303 $13.7 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $4.77 Million - $8.13 Million	129,127 Added 18.57%	824,665 $42.8 Million
Q4 2019 Feb 11, 2020	SELL	$47.06 - $56.64 $708,017 - $852,148	-15,045 Reduced 2.12%	695,538 $39.2 Million
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $7.61 Million - $9.31 Million	-160,354 Reduced 18.41%	710,583 $33.9 Million
Q2 2019 Aug 16, 2019	BUY	$39.26 - $54.21 $4.65 Million - $6.42 Million	118,380 Added 15.73%	870,937 $47.2 Million
Q1 2019 May 14, 2019	BUY	$29.84 - $43.92 $1.07 Million - $1.58 Million	35,895 Added 5.01%	752,557 $30.5 Million
Q4 2018 Feb 07, 2019	BUY	$29.95 - $46.34 $955,195 - $1.48 Million	31,893 Added 4.66%	716,662 $22.3 Million
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $8.29 Million - $9.41 Million	206,552 Added 43.19%	684,769 $31.2 Million
Q2 2018 Aug 10, 2018	BUY	$38.72 - $42.52 $6.09 Million - $6.69 Million	157,255 Added 48.99%	478,217 $20 Million
Q1 2018 May 07, 2018	BUY	$39.4 - $47.39 $2.03 Million - $2.44 Million	51,566 Added 19.14%	320,962 $13.2 Million
Q4 2017 Feb 12, 2018	BUY	$37.27 - $43.02 $3.11 Million - $3.59 Million	83,396 Added 44.84%	269,396 $11.1 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $6.28 Million - $7.75 Million	186,000	186,000 $7.43 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Catalent, Inc. Transaction History